Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,396) with videos related to
Page
of 140
Sort By:
Cancer
|
January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Microbiology
|
August 30, 2001
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results
B Van Der Pol, D H Martin, J Schachter, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 22, 2004
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes
William E Berger, Antonio P Legorreta, Michael S Blaiss, et al.
Nature Genetics
|
May 1, 1997
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
E Rao, B Weiss, M Fukami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Neuropharmacology
|
December 30, 2022
Canalization and plasticity in psychopathology
R L Carhart-Harris, S Chandaria, D E Erritzoe, et al.
Immunology Letters
|
June 16, 1999
Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection
A M García, V F Ortíz-Navarrete, M L Mora-García, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment
Hong Zhou, Suhendan Ekmekcioglu, John W Marks, et al.
The American Journal of Psychiatry
|
June 1, 2012
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success
Li-Shiun Chen, Timothy B Baker, Megan E Piper, et al.
Journal of Consulting and Clinical Psychology
|
June 1, 1997
Evidence that therapy works in clinically representative conditions
W R Shadish, G E Matt, A M Navarro, et al.
Page
of 140
Search research articles
Search
Showing results (1321-1330 of 1,396) with videos related to
Sort By:
Page
of 140
Cancer
|
January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B
N I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Microbiology
|
August 30, 2001
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results
B Van Der Pol, D H Martin, J Schachter, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 22, 2004
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes
William E Berger, Antonio P Legorreta, Michael S Blaiss, et al.
Nature Genetics
|
May 1, 1997
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
E Rao, B Weiss, M Fukami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Neuropharmacology
|
December 30, 2022
Canalization and plasticity in psychopathology
R L Carhart-Harris, S Chandaria, D E Erritzoe, et al.
Immunology Letters
|
June 16, 1999
Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection
A M García, V F Ortíz-Navarrete, M L Mora-García, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment
Hong Zhou, Suhendan Ekmekcioglu, John W Marks, et al.
The American Journal of Psychiatry
|
June 1, 2012
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success
Li-Shiun Chen, Timothy B Baker, Megan E Piper, et al.
Journal of Consulting and Clinical Psychology
|
June 1, 1997
Evidence that therapy works in clinically representative conditions
W R Shadish, G E Matt, A M Navarro, et al.
Page
of 140